14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 26, 2024 Buy 69 000 Robertson Sanford Common Stock
Apr 26, 2024 Sell 46 000 Robertson Sanford Common Stock Warrant
Apr 23, 2024 Buy 176 085 Barry Richard Common Stock
Apr 23, 2024 Sell 117 390 Barry Richard Common Stock Warrant
Apr 18, 2024 Buy 1 500 Kupiec James William Common Stock
Apr 18, 2024 Sell 1 000 Kupiec James William Common Stock Warrant
Apr 17, 2024 Buy 1 500 Schoen Eric Common Stock
Apr 17, 2024 Sell 1 000 Schoen Eric Common Stock Warrant
Jan 03, 2024 Buy 354 740 Robertson Sanford Common Stock Warrant
Jan 03, 2024 Buy 72 000 Robertson Sanford Common Stock Warrant
Jan 03, 2024 Buy 117 390 Barry Richard Common Stock Warrant
Jan 03, 2024 Buy 1 000 Kupiec James William Common Stock Warrant
Jan 03, 2024 Buy 7 920 Schoen Eric Common Stock Warrant
Jan 03, 2024 Buy 800 Schoen Eric Common Stock Warrant
Dec 06, 2023 Buy 20 000 Nicaise Claude Stock Option (Right to Buy)
Dec 06, 2023 Buy 0 Nicaise Claude
Dec 06, 2023 Buy 20 000 Gravier Pierre Stock Option (Right to Buy)
Dec 06, 2023 Buy 20 000 Anderson Robert Eugene Jr Stock Option (Right to Buy)
Dec 06, 2023 Buy 0 Gravier Pierre
Dec 06, 2023 Buy 0 Anderson Robert Eugene Jr
Oct 03, 2023 Buy 150 000 Schoen Eric Stock Option (Right to Buy)
Oct 03, 2023 Buy 50 000 Cook Robert Christopher Stock Option (Right to Buy)
Oct 03, 2023 Buy 150 000 Kupiec James William Stock Option (Right to Buy)
Oct 03, 2023 Buy 300 000 Barbier Remi Stock Option (Right to Buy)
Oct 03, 2023 Buy 150 000 Barbier Remi Stock Option (Right to Buy)
Aug 23, 2023 Buy 30 000 Robertson Sanford Common Stock
Aug 22, 2023 Buy 16 571 Barry Richard Common Stock
Aug 21, 2023 Buy 1 906 Barry Richard Common Stock
Jun 12, 2023 Sell 1 000 Scannon Patrick J Md Phd Stock Option (Right to Buy)
Jun 12, 2023 Buy 1 000 Scannon Patrick J Md Phd Common Stock
May 24, 2023 Buy 71 428 Barbier Remi Common Stock
May 24, 2023 Sell 47 723 Barbier Remi Common Stock
May 24, 2023 Buy 14 285 Barbier Remi Common Stock
May 24, 2023 Sell 9 545 Barbier Remi Common Stock
May 24, 2023 Sell 71 428 Barbier Remi Stock Option (Right to Buy)
May 10, 2023 Buy 2 142 Robertson Sanford Common Stock
May 10, 2023 Buy 3 571 Robertson Sanford Common Stock
May 10, 2023 Buy 3 571 Robertson Sanford Common Stock
May 10, 2023 Sell 3 571 Robertson Sanford Stock Option (Right to Buy)
May 10, 2023 Sell 2 142 Robertson Sanford Stock Opton (Right to Buy)
May 04, 2023 Buy 20 000 Scannon Patrick J Md Phd Stock Option (Right to Buy)
May 04, 2023 Buy 20 000 Robertson Sanford Stock Option (Right to Buy)
May 04, 2023 Buy 5 000 Robertson Sanford Stock Option (Right to Buy)
May 04, 2023 Buy 20 000 O Donnell Michael J Stock Option (Right to Buy)
May 04, 2023 Buy 20 000 Gussin Robert Z Stock Option (Right to Buy)
May 04, 2023 Buy 5 000 Gussin Robert Z Stock Option (Right to Buy)
May 04, 2023 Buy 20 000 Barry Richard Stock Option (Right to Buy)
May 04, 2023 Buy 5 000 Barry Richard Stock Option (Right to Buy)
May 01, 2023 Buy 3 571 Gussin Robert Z Common Stock
May 01, 2023 Buy 3 571 Gussin Robert Z Common Stock
May 01, 2023 Buy 7 077 Gussin Robert Z Common Stock
May 01, 2023 Buy 2 142 Gussin Robert Z Common Stock
May 01, 2023 Sell 3 571 Gussin Robert Z Stock Option (Right to Buy)
May 01, 2023 Sell 3 571 Gussin Robert Z Stock Option (Right to Buy)
Mar 07, 2023 Buy 3 571 O Donnell Michael J Common Stock
Mar 07, 2023 Sell 2 361 O Donnell Michael J Common Stock
Mar 07, 2023 Buy 3 571 O Donnell Michael J Common Stock
Mar 07, 2023 Sell 2 778 O Donnell Michael J Common Stock
Mar 07, 2023 Sell 3 571 O Donnell Michael J Stock Option (Right to Buy)
Mar 07, 2023 Sell 3 571 O Donnell Michael J Stock Option (Right to Buy)
Mar 07, 2023 Buy 77 276 Barry Richard Common Stock
Mar 06, 2023 Buy 11 565 Barry Richard Common Stock
Dec 31, 2022 Buy 0 Barbier Remi Common Stock
Oct 28, 2022 Buy 100 000 Cook Robert Christopher Employee Stock Option (right to buy)
Oct 28, 2022 Buy 0 Cook Robert Christopher
Oct 28, 2022 Buy 0 Cook Robert Christopher
Oct 03, 2022 Buy 9 376 Friedmann Nadav Common Stock
Oct 03, 2022 Sell 9 376 Friedmann Nadav Common Stock
Sep 08, 2022 Sell 2 802 Robertson Sanford Common Stock
Aug 23, 2022 Buy 36 159 Barry Richard Common Stock
Aug 23, 2022 Buy 2 500 Kupiec James William Common Stock
Aug 12, 2022 Buy 2 500 Schoen Eric Common Stock
Aug 12, 2022 Buy 100 000 Robertson Sanford Common Stock
Jun 06, 2022 Buy 65 368 Barbier Remi Common Stock
Jun 06, 2022 Sell 54 720 Barbier Remi Common Stock
Jun 06, 2022 Sell 65 368 Barbier Remi Common Stock
May 27, 2022 Buy 24 513 Friedmann Nadav Common Stock
May 27, 2022 Sell 21 498 Friedmann Nadav Common Stock
Apr 25, 2022 Buy 4 669 Barbier Remi Common Stock
Apr 25, 2022 Buy 44 791 Barbier Remi Common Stock
Apr 25, 2022 Sell 44 791 Barbier Remi Common Stock
Apr 25, 2022 Sell 4 669 Barbier Remi Common Stock
Mar 29, 2022 Buy 4 669 Gussin Robert Z Common Stock
Mar 29, 2022 Sell 4 024 Gussin Robert Z Common Stock
Mar 25, 2022 Buy 4 670 Robertson Sanford Common Stock
Dec 31, 2021 Buy 0 Schoen Eric Common Stock
Dec 31, 2021 Buy 0 Friedmann Nadav Common Stock
Sep 15, 2021 Buy 2 801 Gussin Robert Z Common Stock
Sep 15, 2021 Sell 1 746 Gussin Robert Z Common Stock
Sep 15, 2021 Sell 2 801 Gussin Robert Z Common Stock
Jul 20, 2021 Buy 2 801 Barbier Remi Common Stock
Jul 20, 2021 Sell 2 801 Barbier Remi Common Stock
Jun 11, 2021 Buy 0 Barry Richard Common Stock
May 27, 2021 Buy 56 030 Barbier Remi Common Stock
May 27, 2021 Sell 53 965 Barbier Remi Common Stock
May 27, 2021 Sell 56 030 Barbier Remi Common Stock
Mar 30, 2021 Buy 4 670 Robertson Sanford Common Stock
Mar 30, 2021 Buy 2 802 Robertson Sanford Common Stock
Mar 30, 2021 Sell 2 802 Robertson Sanford Common Stock
Mar 30, 2021 Sell 4 670 Robertson Sanford Common Stock
INSIDER POWER
71.086
Last 100 transactions
Buy: 2 502 072 | Sell: 652 285 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 71.086.

In total, the insiders bought 2 502 072 and sold 652 285 SAVA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Cassava Sciences Inc.

Cassava Sciences Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci... SAVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT